June 21, 2018
Sponsored by

Evaluation & Implementation of NGS Liquid Biopsy Assays


Berlin Institute of Health Genomics Core Platform

This webinar provides a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.

Interest in liquid biopsy has escalated in recent years due to the minimally invasive sampling method, potential to overcome the challenges of tumor heterogeneity, and the potential for longitudinal monitoring of tumor burden through serial sampling.  Furthermore, the growing adoption of NGS allows more labs to perform NGS liquid biopsy tests in house.

In this webinar, Dr. Tomasz Zemojtel of the Berlin Institute of Health discusses how his lab implemented Roche's Avenio ctDNA Analysis Kits for in-house clinical research testing. He will discuss:

  • Utility and flexibility of liquid biopsy assays for various research applications
  • Specific parts of the liquid biopsy workflow that are critical for achieving high technical performance and accurate results, such as molecular barcoding and hybrid capture technology
  • Implementation strategy for liquid biopsy assays using artificial plasma samples
  • Data analysis and interpretation

Lastly, Dr. Zemojtel discusses the data obtained with the Avenio assay workflow from clinical research subjects with ovarian cancer.

Sponsored by

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.

Sponsored by

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Sponsored by

This webinar will discuss ongoing work to apply T-cell receptor sequencing (TCRseq) approaches to immunotherapy monitoring for melanoma patients.